M. Verdirame

A novel series of potent and selective ketone histone deacetylase inhibitors with antitumor activity in vivo.

R. De Francesco, S. Altamura, M. Rowley, 2008, Journal of medicinal chemistry.

DEVELOPMENT AND VALIDATION OF A HIGH-THROUGHPUT RADIOMETRIC CYP3A4/5 INHIBITION ASSAY USING TRITIATED TESTOSTERONE

R. Laufer, F. Peláez, Manuel Sánchez, 2005, Drug Metabolism and Disposition.

ApoA-I mimetic peptides promote pre-β HDL formation in vivo causing remodeling of HDL and triglyceride accumulation at higher dose.

F. Bonelli, B. Hubbard, A. Pessi, 2010, Bioorganic & medicinal chemistry.

An oral TLR7 agonist is a potent adjuvant of DNA vaccination in transgenic mouse tumor models

G. Ciliberto, S. Dharmapuri, L. Aurisicchio, 2009, Cancer Gene Therapy.

Discovery and synthesis of HIV integrase inhibitors: development of potent and orally bioavailable N-methyl pyrimidones.

Michael Rowley, Cristina Gardelli, Marco Ferrara, 2007, Journal of medicinal chemistry.

Turbulent flow chromatography TFC-tandem mass spectrometry supporting in vitro/vivo studies of NCEs in high throughput fashion.

F. Bonelli, A. Di Marco, E. Monteagudo, 2010, Journal of pharmaceutical and biomedical analysis.

SAR and pharmacokinetic studies on phenethylamide inhibitors of the hepatitis C virus NS3/NS4A serine protease.

F. Narjes, I. Stansfield, V. Matassa, 2004, Bioorganic & medicinal chemistry letters.